Binding properties of human immunodeficiency virus type-2 (HIV-2) RNA corresponding to the packaging signal to its nucleocapsid protein
- PMID: 8886267
- DOI: 10.1080/15216549600201502
Binding properties of human immunodeficiency virus type-2 (HIV-2) RNA corresponding to the packaging signal to its nucleocapsid protein
Abstract
The nucleocapsid (NC) protein of human immunodeficiency virus type-1 (HIV-1) contains two zinc finger motifs (ZFMs), and binds specifically to the packaging signal which is located in the 5' leader sequence of the viral genomic RNA between the first splice donor and the gag initiator codon (AUG). In this study, we analyzed the specificity of the binding of the corresponding region of HIV-2 (Region 3) to its NC protein (NCp8), by performing a competitive ultraviolet (UV) cross-linking assay using in vitro-synthesized 32P-labeled and unlabeled RNAs corresponding to a sequence between the primer binding site and the gag AUG (Region 1). Binding of 32P-labeled Region 1 RNA to NCp8 was inhibited specifically by adding unlabeled Region 1 and 3 RNAs and no specific binding was detected using deletion mutant peptides of NCp8. These findings suggest that the region(s) which bind(s) specifically to HIV-2 NCp8 lie(s) between the first splice donor and the gag AUG in the 5' leader sequence and that NCp8 is the minimum binding region responsible for the specific binding of the region downstream of the first splice donor site of HIV-2 RNA.
Similar articles
-
Mapping the RNA binding sites for human immunodeficiency virus type-1 gag and NC proteins within the complete HIV-1 and -2 untranslated leader regions.Nucleic Acids Res. 1998 Aug 15;26(16):3667-76. doi: 10.1093/nar/26.16.3667. Nucleic Acids Res. 1998. PMID: 9685481 Free PMC article.
-
Viral RNA binding properties of human immunodeficiency virus type-2 (HIV-2) nucleocapsid protein-derived synthetic peptides.Biochem Mol Biol Int. 1996 May;38(6):1143-54. Biochem Mol Biol Int. 1996. PMID: 8739036
-
High-resolution solution NMR structure of the minimal active domain of the human immunodeficiency virus type-2 nucleocapsid protein.Biochemistry. 1998 Dec 22;37(51):17704-13. doi: 10.1021/bi981818o. Biochemistry. 1998. PMID: 9922136
-
Viral RNA-binding activity of HIV-2 nucleocapsid protein is inhibited by a synthetic peptide containing the first zinc finger motif of HIV-2.AIDS. 1994 Sep;8(9):1227-35. doi: 10.1097/00002030-199409000-00003. AIDS. 1994. PMID: 7802975
-
Human immunodeficiency virus type 2 (HIV-2): packaging signal and associated negative regulatory element.Hum Gene Ther. 1995 Feb;6(2):177-84. doi: 10.1089/hum.1995.6.2-177. Hum Gene Ther. 1995. PMID: 7734518
Cited by
-
Human Retrovirus Genomic RNA Packaging.Viruses. 2022 May 19;14(5):1094. doi: 10.3390/v14051094. Viruses. 2022. PMID: 35632835 Free PMC article. Review.
-
Structural dynamics of retroviral genome and the packaging.Front Microbiol. 2011 Dec 29;2:264. doi: 10.3389/fmicb.2011.00264. eCollection 2011. Front Microbiol. 2011. PMID: 22232618 Free PMC article.
-
Mapping the RNA binding sites for human immunodeficiency virus type-1 gag and NC proteins within the complete HIV-1 and -2 untranslated leader regions.Nucleic Acids Res. 1998 Aug 15;26(16):3667-76. doi: 10.1093/nar/26.16.3667. Nucleic Acids Res. 1998. PMID: 9685481 Free PMC article.